AR037371A1 - Compuesto macrolida, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso para la preparacion de un medicamento - Google Patents
Compuesto macrolida, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso para la preparacion de un medicamentoInfo
- Publication number
- AR037371A1 AR037371A1 ARP020104364A ARP020104364A AR037371A1 AR 037371 A1 AR037371 A1 AR 037371A1 AR P020104364 A ARP020104364 A AR P020104364A AR P020104364 A ARP020104364 A AR P020104364A AR 037371 A1 AR037371 A1 AR 037371A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- optionally substituted
- alkyl
- bicyclic heteroaryl
- hydroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229940126601 medicinal product Drugs 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 22
- 239000001257 hydrogen Substances 0.000 abstract 22
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 22
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 4
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 4
- 125000004429 atom Chemical group 0.000 abstract 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 4
- 125000004122 cyclic group Chemical group 0.000 abstract 4
- 229910052731 fluorine Chemical group 0.000 abstract 4
- 239000011737 fluorine Chemical group 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000012453 solvate Substances 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 2
- 101100240518 Caenorhabditis elegans nhr-12 gene Proteins 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 2
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Chemical group 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 230000009885 systemic effect Effects 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 125000004001 thioalkyl group Chemical group 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0127349.9A GB0127349D0 (en) | 2001-11-14 | 2001-11-14 | Macrolides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR037371A1 true AR037371A1 (es) | 2004-11-03 |
Family
ID=9925777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020104364A AR037371A1 (es) | 2001-11-14 | 2002-11-13 | Compuesto macrolida, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso para la preparacion de un medicamento |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7202221B2 (enExample) |
| EP (1) | EP1453846B1 (enExample) |
| JP (1) | JP2005515978A (enExample) |
| CN (1) | CN1307194C (enExample) |
| AR (1) | AR037371A1 (enExample) |
| AT (1) | ATE362479T1 (enExample) |
| BR (1) | BR0214132A (enExample) |
| CA (1) | CA2466975A1 (enExample) |
| DE (1) | DE60220180T2 (enExample) |
| EA (1) | EA007433B1 (enExample) |
| ES (1) | ES2287332T3 (enExample) |
| GB (1) | GB0127349D0 (enExample) |
| HR (1) | HRP20040433A2 (enExample) |
| HU (1) | HUP0402225A3 (enExample) |
| IL (1) | IL161710A0 (enExample) |
| PL (1) | PL371472A1 (enExample) |
| RS (1) | RS41904A (enExample) |
| UA (1) | UA77210C2 (enExample) |
| WO (1) | WO2003042228A1 (enExample) |
| ZA (1) | ZA200403684B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6995143B2 (en) * | 2002-02-28 | 2006-02-07 | Basilea Pharmaceutica Ag | Macrolides with antibacterial activity |
| US7022679B2 (en) | 2002-05-13 | 2006-04-04 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 6-11 bicyclic erythromycin derivatives |
| US7135573B2 (en) | 2002-05-13 | 2006-11-14 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine |
| US7910558B2 (en) | 2002-05-13 | 2011-03-22 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
| US6764998B1 (en) | 2003-06-18 | 2004-07-20 | Enanta Pharmaceuticals, Inc. | 6,11-4C-bicyclic 9a-azalide derivatives |
| JP4532263B2 (ja) * | 2002-05-14 | 2010-08-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 置換されたキノロンカルボン酸、その誘導体、作用の部位、およびその使用 |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| GB0225384D0 (en) * | 2002-10-31 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
| US6645941B1 (en) | 2003-03-26 | 2003-11-11 | Enanta Pharmaceuticals, Inc. | 6,11-3C-bicyclic 9a-azalide derivatives |
| CL2004001012A1 (es) * | 2003-05-13 | 2005-03-18 | Glaxo Group Ltd | Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica |
| GB0310986D0 (en) | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| GB0310980D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| GB0310979D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| GB0310984D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| US7276487B2 (en) | 2003-09-23 | 2007-10-02 | Enanta Pharmaceuticals, Inc. | 9a, 11-3C-bicyclic 9a-azalide derivatives |
| WO2005070113A2 (en) | 2004-01-09 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | 9n-substituted 6-11 bicyclic erythromycin derivatives |
| EP1723159B1 (en) | 2004-02-27 | 2019-06-12 | Melinta Therapeutics, Inc. | Macrocyclic compounds and methods of making and using the same |
| BRPI0510328A (pt) * | 2004-05-06 | 2007-10-23 | Glaxosmithkline Zagreb | macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas |
| EP1756134A1 (en) * | 2004-05-06 | 2007-02-28 | GlaxoSmithKline istrazivacki centar Zagreb d.o.o. | Carbamate linked macrolides useful for the treatment of microbial infections |
| WO2006047167A2 (en) * | 2004-10-21 | 2006-05-04 | Janssen Pharmaceutica, N.V. | 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials |
| GB0424951D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| GB0424961D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| GB0424958D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| GB0424959D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| KR101239490B1 (ko) * | 2006-08-09 | 2013-03-05 | 바실리어 파마슈티카 아게 | 염증성 및 알러지성 질환에 유용한 새로운 마크로라이드 |
| WO2008023248A2 (en) | 2006-08-24 | 2008-02-28 | Wockhardt Research Centre | Novel macrolides and ketolides having antimicrobial activity |
| MX2010008750A (es) | 2008-02-08 | 2010-08-31 | Basilea Pharmaceutica Ag | Nuevos macrolidos y su uso. |
| MX2011012614A (es) | 2009-05-27 | 2012-02-22 | Wockhardt Ltd | Compuestos de quetolida que tienen actividad antimicrobiana. |
| RU2601550C2 (ru) | 2010-12-09 | 2016-11-10 | Вокхардт Лимитед | Кетолидные соединения |
| BR112013019283A2 (pt) * | 2011-01-31 | 2016-09-13 | Meiji Seika Pharma Co Ltd | composto, fármaco, composição farmacêutica e uso |
| JP5718488B2 (ja) | 2011-03-01 | 2015-05-13 | ウォックハート リミテッド | ケトライド中間体の調製方法 |
| CN119060110A (zh) * | 2023-05-30 | 2024-12-03 | 北京理工大学 | 一种红霉素衍生物及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0126344A2 (en) | 1983-05-20 | 1984-11-28 | Abbott Laboratories | Tripeptide esters of therapeutic agents |
| US4742049A (en) * | 1986-06-04 | 1988-05-03 | Abbott Laboratories | Semisynthetic erythromycin antibiotics |
| AU623764B2 (en) | 1989-03-28 | 1992-05-21 | Abbott Laboratories | Erythromycin derivatives |
| CA2064634C (en) * | 1991-04-04 | 1998-08-04 | James V. Heck | 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions |
| WO1997042206A1 (en) | 1996-05-07 | 1997-11-13 | Abbott Laboratories | 6-o-substituted erythromycin compounds and method for making same |
| EP0895999A1 (en) * | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | C-4" substituted macrolide antibiotics |
| US6262030B1 (en) * | 1998-11-03 | 2001-07-17 | Pfizer Inc. | Erythromycin derivatives |
| OA11945A (en) | 1999-05-24 | 2006-04-13 | Pfizer Prod Inc | 13-Methyl erythromycin derivatives. |
| AU6748500A (en) | 1999-08-24 | 2001-03-19 | Abbott Laboratories | 9a-azalides with antibacterial activity |
| CA2398848C (en) | 2000-02-24 | 2007-09-25 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
| US6946446B2 (en) * | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
| JP2002173498A (ja) | 2000-09-27 | 2002-06-21 | Hokuriku Seiyaku Co Ltd | エリスロマイシン誘導体 |
| GB0025688D0 (en) * | 2000-10-19 | 2000-12-06 | Glaxo Group Ltd | Macrolides |
-
2001
- 2001-11-14 GB GBGB0127349.9A patent/GB0127349D0/en not_active Ceased
-
2002
- 2002-11-13 BR BR0214132-9A patent/BR0214132A/pt not_active IP Right Cessation
- 2002-11-13 DE DE60220180T patent/DE60220180T2/de not_active Expired - Fee Related
- 2002-11-13 WO PCT/GB2002/005101 patent/WO2003042228A1/en not_active Ceased
- 2002-11-13 CN CNB028270452A patent/CN1307194C/zh not_active Expired - Fee Related
- 2002-11-13 IL IL16171002A patent/IL161710A0/xx unknown
- 2002-11-13 JP JP2003544063A patent/JP2005515978A/ja active Pending
- 2002-11-13 EP EP02779670A patent/EP1453846B1/en not_active Expired - Lifetime
- 2002-11-13 EA EA200400536A patent/EA007433B1/ru not_active IP Right Cessation
- 2002-11-13 US US10/495,413 patent/US7202221B2/en not_active Expired - Fee Related
- 2002-11-13 HR HR20040433A patent/HRP20040433A2/hr not_active Application Discontinuation
- 2002-11-13 HU HU0402225A patent/HUP0402225A3/hu unknown
- 2002-11-13 RS YU41904A patent/RS41904A/sr unknown
- 2002-11-13 PL PL02371472A patent/PL371472A1/xx not_active Application Discontinuation
- 2002-11-13 UA UA20040503313A patent/UA77210C2/uk unknown
- 2002-11-13 AT AT02779670T patent/ATE362479T1/de not_active IP Right Cessation
- 2002-11-13 ES ES02779670T patent/ES2287332T3/es not_active Expired - Lifetime
- 2002-11-13 AR ARP020104364A patent/AR037371A1/es unknown
- 2002-11-13 CA CA002466975A patent/CA2466975A1/en not_active Abandoned
-
2004
- 2004-05-13 ZA ZA200403684A patent/ZA200403684B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL371472A1 (en) | 2005-06-13 |
| WO2003042228A1 (en) | 2003-05-22 |
| JP2005515978A (ja) | 2005-06-02 |
| ES2287332T3 (es) | 2007-12-16 |
| DE60220180D1 (de) | 2007-06-28 |
| DE60220180T2 (de) | 2008-01-17 |
| EP1453846B1 (en) | 2007-05-16 |
| EA007433B1 (ru) | 2006-10-27 |
| US7202221B2 (en) | 2007-04-10 |
| ATE362479T1 (de) | 2007-06-15 |
| CN1612888A (zh) | 2005-05-04 |
| CA2466975A1 (en) | 2003-05-22 |
| HUP0402225A3 (en) | 2006-01-30 |
| ZA200403684B (en) | 2005-09-13 |
| EA200400536A1 (ru) | 2004-12-30 |
| IL161710A0 (en) | 2004-09-27 |
| RS41904A (sr) | 2006-10-27 |
| HUP0402225A2 (hu) | 2005-02-28 |
| EP1453846A1 (en) | 2004-09-08 |
| GB0127349D0 (en) | 2002-01-02 |
| UA77210C2 (en) | 2006-11-15 |
| CN1307194C (zh) | 2007-03-28 |
| BR0214132A (pt) | 2004-09-14 |
| US20050080025A1 (en) | 2005-04-14 |
| HRP20040433A2 (en) | 2005-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR037371A1 (es) | Compuesto macrolida, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso para la preparacion de un medicamento | |
| HUP0302526A2 (hu) | Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0004076A2 (hu) | C-4"-Szubsztituált-makrolid-származékok | |
| MXPA03005464A (es) | Agentes antivirales. | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| ATE286501T1 (de) | Pyrimidinderivate | |
| DK1179341T3 (da) | Lægemidler eller forebyggende midler mod sygdomme der er associeret med chemokiner | |
| AR061422A2 (es) | Peptidos ciclicos selectivos, procedimiento de preparacion, composicion farmaceutica que los comprende, y uso de los mismos en la preparacion de medicamentos | |
| CY1111980T1 (el) | Παραγωγα του αμιδιου τα οποια φερουν ενα υποκαταστατο του κυκλοπροπυλαμινοκαρβονυλιου και χρησιμευουν ως αναστολεις κυτταροκινης | |
| AR015312A1 (es) | Compuestos inhibidores no peptidilicos de la union a las celulas dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunesy respiratorias, composicion farmaceutica y uso de los compuestos en la preparacion de medicamentos | |
| AR015769A1 (es) | Derivados de imidazo piridina que inhiben la secrecion de acido gastrico, procedimiento para la preparacion de dichos derivados, composicion farmaceutica, uso de dichos derivados para la preparacion de medicamentos, y compuestos intermediarios. | |
| TR200103395T2 (tr) | 13-metil eritromisin türevleri. | |
| CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
| WO2004018475A3 (en) | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents | |
| SE9901573D0 (sv) | New compounds | |
| DK0992509T3 (da) | Nye makrolid-derivater | |
| AR044304A1 (es) | Compuesto de macrolido de 14 y 15 miembros sustituido en la posicion 4'', procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende | |
| BR0008321A (pt) | Secretagogos de hormÈnio de crescimento | |
| AR041860A1 (es) | Compuesto macrolido de oxima sustituido en la posicion 4'', procedimiento de preparacion del mismo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende | |
| AR044869A1 (es) | Compuesto de dicetopiperazina, composicion farmaceutica que lo comprende, su uso para fabricar un medicamento y procedimiento para su preparacion | |
| JO1629B1 (en) | Andadnodol compounds i | |
| SE9901572D0 (sv) | New compounds | |
| BR0013435A (pt) | Composto, um derivado de éster, de éter ou de n-alquila farmaceuticamente aceitável do mesmo ou um sal farmaceuticamente aceitável dos mesmos, medicamento, composição e método para a prevenção ou tratamento de uma infeção, e, uso de um composto | |
| ES343818A1 (es) | Procedimiento para la obtencion de nuevas 3-amino - sidno- minas sustituidas. | |
| AR044310A1 (es) | Compuesto de macrolido de 15 miembros sustituido en la posicion 4", procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |